The FTC Takes On Pharmaceutical Benefit Managers

Alden Abbott October 11, 2024

Truth on the Market View Original Source

• 
  Back
  to Top

The Federal Trade Commission (FTC) announced Sept. 20 that it was suing the three largest pharmaceutical benefit managers (PBMs)—Caremark Rx, Express Scripts (ESI), and Optum—alleging competition and consumer-protection law violations.

This commentary provides information on controversies surrounding the economic effects of PBMs that led up to the suit. A follow-up commentary will assess the lawsuit itself.

Read the full piece here.